PRISMDIRECT Trademark

Trademark Overview

On Friday, December 8, 2023, a trademark application was filed for PRISMDIRECT with the United States Patent and Trademark Office. The USPTO has given the PRISMDIRECT trademark a serial number of 98305240. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, July 15, 2024. This trademark is owned by Scipher Medicine Corporation. The PRISMDIRECT trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing collected and analyzed medical information in the field of autoimmune diseases and treatment information for complex diseases and disorders for diagnostic and treatment purposes; providing medical data and information to pharmaceutical companies and healthcare providers; medical screening information services featuring alerts to pharmaceutical companies related to healthcare providers ordering medical diagnostic testing for patients; providing healthcare information and medical diagnostic services in the field of precision medicine, personalized medicine, and autoimmune disease; providing information in the fields of autoimmune diseases and pharmaceuticals

Data mining services in the field of precision medicine, personalized medicine and genomic sequencing; providing an AI-based data analytics platform in the field of precision medicine, personalized medicine, genomic sequencing and autoimmune diseases; software as a service (SAAS) featuring AI-based software for patient analytics in the field of precision medicine, personalized medicine, and autoimmune diseases; platform as a service (PAAS) featuring AI-based software for data analytics related to non-TNFi responder patients; platform as a service (PAAS) featuring AI-based software for use in providing data analytics and data insights; technology driven research, consultation, and platform services, namely consulting and providing PAAS featuring AI-based software in the field of precision medicine, personalized medicine and autoimmune diseases; diagnostic laboratory services in the field of precision medicine; scientific research in the field of disease modeling and precision medicine
prismdirect

General Information

Serial Number98305240
Word MarkPRISMDIRECT
Filing DateFriday, December 8, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, July 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkPRISM DIRECT
Goods and ServicesProviding collected and analyzed medical information in the field of autoimmune diseases and treatment information for complex diseases and disorders for diagnostic and treatment purposes; providing medical data and information to pharmaceutical companies and healthcare providers; medical screening information services featuring alerts to pharmaceutical companies related to healthcare providers ordering medical diagnostic testing for patients; providing healthcare information and medical diagnostic services in the field of precision medicine, personalized medicine, and autoimmune disease; providing information in the fields of autoimmune diseases and pharmaceuticals
Goods and ServicesData mining services in the field of precision medicine, personalized medicine and genomic sequencing; providing an AI-based data analytics platform in the field of precision medicine, personalized medicine, genomic sequencing and autoimmune diseases; software as a service (SAAS) featuring AI-based software for patient analytics in the field of precision medicine, personalized medicine, and autoimmune diseases; platform as a service (PAAS) featuring AI-based software for data analytics related to non-TNFi responder patients; platform as a service (PAAS) featuring AI-based software for use in providing data analytics and data insights; technology driven research, consultation, and platform services, namely consulting and providing PAAS featuring AI-based software in the field of precision medicine, personalized medicine and autoimmune diseases; diagnostic laboratory services in the field of precision medicine; scientific research in the field of disease modeling and precision medicine

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 8, 2023
Primary Code042
First Use Anywhere DateMonday, September 13, 2021
First Use In Commerce DateMonday, September 13, 2021
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 8, 2023
Primary Code044
First Use Anywhere DateMonday, September 13, 2021
First Use In Commerce DateMonday, September 13, 2021

Trademark Owner History

Party NameScipher Medicine Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Friday, December 8, 2023NEW APPLICATION ENTERED
Thursday, March 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 15, 2024NON-FINAL ACTION E-MAILED
Monday, July 15, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 9, 2024ASSIGNED TO EXAMINER

Related Keywords

prismdirect medicine field precision providing information diseases data autoimmune software based